Group One Trading
ACET icon

Group One Trading’s Adicet Bio ACET Stock Holding History

Group One Trading’s Portfolio ACET Stock Details ACET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-425
Closed -$4.48K – 7852
2025
Q1 		$5.13K Sell
425
-275
-39% -$3.93K ﹤0.01% 6629
2024
Q4 		$10.8K Buy
700
+562
+407% +$10.6K ﹤0.01% 6064
2024
Q3 		$3.17K Buy
+138
New +$3.09K ﹤0.01% 6028
2024
Q1 		– Sell
-343
Closed -$14.2K – 6925
2023
Q4 		$10.4K Hold
343
– – ﹤0.01% 6177
2023
Q3 		$7.52K Buy
+343
New +$12.1K ﹤0.01% 6507
2023
Q2 		– Sell
-49
Closed -$4.33K – 7582
2023
Q1 		$4.48K Buy
+49
New +$6.15K ﹤0.01% 6328
2022
Q3 		– Sell
-938
Closed -$219K – 7453
2022
Q2 		$219K Buy
+938
New +$206K ﹤0.01% 4211
2020
Q3 		– Sell
-3
Closed -$1K – 6013
2020
Q2 		$1K Sell
3
-26
-90% -$5.11K ﹤0.01% 5618
2020
Q1 		$3K Buy
29
+22
+314% +$3.27K ﹤0.01% 4866
2019
Q4 		$1K Buy
+7
New +$3.54K ﹤0.01% 4954

Other funds holding ACET

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Group One Trading's ACET Position: Q2 2025 in Review

Group One Trading sold out of Adicet Bio (ACET) in Q2 2025, closing a stake of 425 shares — an estimated $4.48K sold.

Group One Trading first reported a position in ACET in Q4 2019 and held it in 10 quarters. The position peaked at $219K in Q2 2022. 49 funds tracked by Wall St. Rank hold ACET as of Q2 2025.

  • Group One Trading reported no remaining Adicet Bio position as of Q2 2025 after selling out during the quarter.
  • Group One Trading sold 425 Adicet Bio shares in Q2 2025, an estimated $4.48K.
  • Group One Trading first reported a position in Adicet Bio in Q4 2019 and held it in 10 quarters.
  • Group One Trading's Adicet Bio position peaked at $219K in Q2 2022.
  • 49 funds tracked by Wall St. Rank held Adicet Bio as of Q2 2025.

Based on Group One Trading's 13F filing for Q2 2025, filed 14 Aug 2025.